Literature DB >> 8355708

The Ets-related transcription factor PU.1 immortalizes erythroblasts.

S Schuetze1, P E Stenberg, D Kabat.   

Abstract

In vivo studies of Friend virus erythroleukemia have implied that proviral integrations adjacent to the gene for the Ets-related transcription factor PU.1 may inhibit the commitment of erythroblasts to differentiate and cause their capability for indefinite transplantation (C. Spiro, B. Gliniak, and D. Kabat, J. Virol. 62:4129-4135, 1988; R. Paul, S. Schuetze, S. L. Kozak, C. Kozak, and D. Kabat, J. Virol. 65:464-467, 1991). To test this hypothesis, we ligated PU.1 cDNA into a retroviral vector and studied its effects on cultured cells. Infection of fibroblasts with PU.1-encoding retrovirus resulted in PU.1 synthesis followed by nuclear pyknosis, cell rounding, and degeneration. In contrast, in long-term bone marrow cultures, erythroblasts were efficiently and rapidly immortalized. The resulting cell lines were polyclonal populations that contained PU.1, were morphologically blast-like, required erythropoietin and bone marrow stromal cells for survival and proliferation, and spontaneously differentiated at low frequency to synthesize hemoglobin. After 9 months in culture, erythroblasts became stroma independent, and they then grew as clonal cell lines. We conclude that PU.1 perturbs the pathway(s) that controls potential for indefinite proliferation and that it can be used to generate permanent erythroblast cell lines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8355708      PMCID: PMC360299          DOI: 10.1128/mcb.13.9.5670-5678.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  72 in total

1.  Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene.

Authors:  A D Miller; M F Law; I M Verma
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

2.  Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

Authors:  P Shaw; R Bovey; S Tardy; R Sahli; B Sordat; J Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

3.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

4.  Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus.

Authors:  M Mowat; A Cheng; N Kimura; A Bernstein; S Benchimol
Journal:  Nature       Date:  1985 Apr 18-24       Impact factor: 49.962

5.  The binding of human immunoglobulin G1 monomer and small, covalently cross-linked polymers of immunoglobulin G1 to human peripheral blood monocytes and polymorphonuclear leukocytes.

Authors:  R J Kurlander; J Batker
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

6.  Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells.

Authors:  S Schuetze; R Paul; B C Gliniak; D Kabat
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

7.  Transformation of both erythroid and myeloid cells by E26, an avian leukemia virus that contains the myb gene.

Authors:  K Radke; H Beug; S Kornfeld; T Graf
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

8.  c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene.

Authors:  A D Miller; T Curran; I M Verma
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

9.  Malignant transformation of erythroid cells in vivo by introduction of a nonreplicating retrovirus vector.

Authors:  L Wolff; S Ruscetti
Journal:  Science       Date:  1985-06-28       Impact factor: 47.728

10.  Site-directed deletions of Abelson murine leukemia virus define 3' sequences essential for transformation and lethality.

Authors:  S M Watanabe; O N Witte
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

View more
  26 in total

1.  BSAP can repress enhancer activity by targeting PU.1 function.

Authors:  S Maitra; M Atchison
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1.

Authors:  Wei Hong; Alexander Y Kim; Sokun Ky; Carrie Rakowski; Sang-Beom Seo; Debabrata Chakravarti; Michael Atchison; Gerd A Blobel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

3.  Expansion of CD34+ cells on telomerized human stromal cells without losing erythroid-differentiation potential in a serum-free condition.

Authors:  Masayoshi Kobune; Yutaka Kawano; Junji Kato; Yoshinori Ito; Hiroki Chiba; Kiminori Nakamura; Akihito Fujimi; Takuya Matsunaga; Hirofumi Hamada; Yoshiro Niitsu
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

4.  The conserved 5'-untranslated leader of Spi-1 (PU.1) mRNA is highly structured and potently inhibits translation in vitro but not in vivo.

Authors:  J O Hensold; C A Stratton; D Barth
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

5.  Reprogramming leukemia cells to terminal differentiation and growth arrest by RNA interference of PU.1.

Authors:  Michael Papetti; Arthur I Skoultchi
Journal:  Mol Cancer Res       Date:  2007-10       Impact factor: 5.852

6.  Inhibition of hematopoiesis by competitive binding of transcription factor PU.1.

Authors:  M T Voso; T C Burn; G Wulf; B Lim; G Leone; D G Tenen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

7.  Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B.

Authors:  G H Su; H M Chen; N Muthusamy; L A Garrett-Sinha; D Baunoch; D G Tenen; M C Simon
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

8.  PU.1 can participate in an active enhancer complex without its transcriptional activation domain.

Authors:  J M Pongubala; M L Atchison
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

Review 9.  Concise review: production of cultured red blood cells from stem cells.

Authors:  Eric E Bouhassira
Journal:  Stem Cells Transl Med       Date:  2012-11-26       Impact factor: 6.940

10.  Spi-1/PU.1 transgenic mice develop multistep erythroleukemias.

Authors:  F Moreau-Gachelin; F Wendling; T Molina; N Denis; M Titeux; G Grimber; P Briand; W Vainchenker; A Tavitian
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.